Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Erratum

Erratum to ‘Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?’ [Clin Mol Hepatol 2023;29:367-370]

Joo Hyun Oh, Dong Hyun Sinn

Clin Mol Hepatol. 2023;29(3):828-829. Published online April 13, 2023

DOI: https://doi.org/10.3350/cmh.2023.0054e
Corrects: Clin Mol Hepatol 2023;29(2):367

View: 1430 Download: 24

Correspondence

Correspondence on Letter regarding “Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?”

Joo Hyun Oh, Dong Hyun Sinn

Clin Mol Hepatol. 2023;29(3):820-820. Published online May 19, 2023

DOI: https://doi.org/10.3350/cmh.2023.0135

View: 1544 Download: 27

Original Article

Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis

Moon Haeng Hur, Yuri Cho, Do Young Kim, Jae Seung Lee, Gyoung Min Kim, Hyo-Cheol Kim, Dong Hyun Sinn, Dongho Hyun, Han Ah Lee, Yeon Seok Seo, In Joon Lee, Joong-Won Park, Yoon Jun Kim

Clin Mol Hepatol. 2023;29(3):763-778. Published online May 30, 2023

DOI: https://doi.org/10.3350/cmh.2023.0076

View: 2730 Download: 178 Crossref: 2

Editorial

How to optimize the outcome of liver transplantation for non-alcoholic fatty liver disease

Byeong Geun Song, Dong Hyun Sinn

Clin Mol Hepatol. 2023;29(2):411-413. Published online March 6, 2023

DOI: https://doi.org/10.3350/cmh.2023.0058

View: 1994 Download: 46 Web of Science: 1 Crossref: 1

Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?

Joo Hyun Oh, Dong Hyun Sinn

Clin Mol Hepatol. 2023;29(2):367-370. Published online March 20, 2023

DOI: https://doi.org/10.3350/cmh.2023.0054 Correction in: Clin Mol Hepatol 2023;29(3):828

View: 2309 Download: 62 Web of Science: 3 Crossref: 2

Review

Clinical practice guideline and real-life practice in hepatocellular carcinoma: A Korean perspective

Myung Ji Goh, Dong Hyun Sinn, Jong Man Kim, Min Woo Lee, Dong Ho Hyun, Jeong Il Yu, Jung Yong Hong, Moon Seok Choi

Clin Mol Hepatol. 2023;29(2):197-205. Published online January 5, 2023

DOI: https://doi.org/10.3350/cmh.2022.0404

View: 4001 Download: 222 Web of Science: 9 Crossref: 9

Statin and aspirin for chemoprevention of hepatocellular carcinoma: Time to use or wait further?

Myung Ji Goh, Dong Hyun Sinn

Clin Mol Hepatol. 2022;28(3):380-395. Published online January 13, 2022

DOI: https://doi.org/10.3350/cmh.2021.0366

View: 4609 Download: 168 Web of Science: 10 Crossref: 9

Original Article

Substantial risk of recurrence even after 5 recurrence-free years in early-stage hepatocellular carcinoma patients

Jihye Kim, Wonseok Kang, Dong Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik

Clin Mol Hepatol. 2020;26(4):516-528. Published online September 11, 2020

DOI: https://doi.org/10.3350/cmh.2020.0016

View: 6081 Download: 207 Web of Science: 40 Crossref: 40

Review

Comparison of clinical practice guidelines for the management of chronic hepatitis B: When to start, when to change, and when to stop

Hyung Joon Yim, Ji Hoon Kim, Jun Yong Park, Eileen L. Yoon, Hana Park, Jung Hyun Kwon, Dong Hyun Sinn, Sae Hwan Lee, Jeong-Hoon Lee, Hyun Woong Lee

Clin Mol Hepatol. 2020;26(4):411-429. Published online August 28, 2020

DOI: https://doi.org/10.3350/cmh.2020.0049

View: 14413 Download: 1,426 Web of Science: 63 Crossref: 64

Editorial

Low-level viremia in patients undergoing antiviral therapy: Does it indicate time for a change?

Jung Hee Kim, Dong Hyun Sinn

Clin Mol Hepatol. 2020;26(3):315-317. Published online June 23, 2020

DOI: https://doi.org/10.3350/cmh.2020.0084

View: 4560 Download: 103 Crossref: 1

Review

Current status and strategies for the control of viral hepatitis A in Korea

Eileen L. Yoon, Dong Hyun Sinn, Hyun Woong Lee, Ji Hoon Kim

Clin Mol Hepatol. 2017;23(3):196-204. Published online September 19, 2017

DOI: https://doi.org/10.3350/cmh.2017.0034

View: 8922 Download: 206 Web of Science: 18 Crossref: 19

Current status and strategies for viral hepatitis control in Korea

Dong Hyun Sinn, Eun Ju Cho, Ji Hoon Kim, Do Young Kim, Yoon Jun Kim, Moon Seok Choi

Clin Mol Hepatol. 2017;23(3):189-195. Published online September 19, 2017

DOI: https://doi.org/10.3350/cmh.2017.0033

View: 8543 Download: 242 Web of Science: 19 Crossref: 19

Case Report

A case of ruptured hepatic angiomyolipoma in a young male

Sun Hwa Kim, Tae Wook Kang, Kyunghee Lim, Hyun Sung Joh, Jiseok Kang, Dong Hyun Sinn

Clin Mol Hepatol. 2017;23(2):179-183. Published online April 28, 2017

DOI: https://doi.org/10.3350/cmh.2016.0027

View: 8449 Download: 108 Web of Science: 10 Crossref: 13

Original Article

The role of scheduled second TACE in early-stage hepatocellular carcinoma with complete response to initial TACE

Jung Hee Kim, Dong Hyun Sinn, Sung Wook Shin, Sung Ki Cho, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Moon Seok Choi

Clin Mol Hepatol. 2017;23(1):42-50. Published online March 7, 2017

DOI: https://doi.org/10.3350/cmh.2016.0058

View: 9943 Download: 214 Web of Science: 12 Crossref: 11

Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma

Jun Young Kim, Dong Hyun Sinn, Geum-Youn Gwak, Gyu-Seong Choi, Aldosri Meshal Saleh, Jae-Won Joh, Sung Ki Cho, Sung Wook Shin, Keumhee Chough Carriere, Joong Hyun Ahn, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik

Clin Mol Hepatol. 2016;22(2):250-258. Published online June 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0015

View: 11294 Download: 198 Web of Science: 40 Crossref: 40

Static and dynamic prognostic factors for hepatitis-B-related acute-on-chronic liver failure

Jung Min Ha, Won Sohn, Ju Yeon Cho, Jeung Hui Pyo, Kyu Choi, Dong Hyun Sinn, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Chul Koh, Seung Woon Paik, Byung Chul Yoo, Yong-Han Paik

Clin Mol Hepatol. 2015;21(3):232-241. Published online September 30, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.3.232

View: 7641 Download: 89 Web of Science: 7 Crossref: 7

Case Report

Pure red-cell aplasia and autoimmune hemolytic anemia in a patient with acute hepatitis A

Hyo Jeong Chang, Dong Hyun Sinn, Sung Gyun Cho, Tae Hoon Oh, Tae Joo Jeon, Won Chang Shin, Won Choong Choi

Clin Mol Hepatol. 2014;20(2):204-207. Published online June 30, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.2.204

View: 8218 Download: 118 Web of Science: 8 Crossref: 8

Editorial

Are patients with alcohol-related fatty liver at increased risk of coronary heart disease?

Dong Hyun Sinn, Yong-Han Paik

Clin Mol Hepatol. 2014;20(2):151-153. Published online June 30, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.2.151

View: 5117 Download: 75

Case Report

Hepatoid adenocarcinoma of the stomach: an unusual case of elevated alpha-fetoprotein with prior treatment for hepatocellular carcinoma

Joon Seong Ahn, Ja Ryong Jeon, Hong Seok Yoo, Taek Kyu Park, Cheol Keun Park, Dong Hyun Sinn, Seung Woon Paik

Clin Mol Hepatol. 2013;19(2):173-178. Published online June 27, 2013

DOI: https://doi.org/10.3350/cmh.2013.19.2.173

View: 7718 Download: 69 Crossref: 8

1 |

Viewed By 5301	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5246	MAFLD: How is it different from NAFLD?
Viewed By 5150	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3862	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3801	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

Search